scholarly article | Q13442814 |
P50 | author | Jenny L. Wiley | Q42407062 |
P2093 | author name string | Nicholas C Peiper | |
Scott P Novak | |||
Timothy W Lefever | |||
Sheryl C Cates | |||
Camille K Gourdet | |||
Daniel G Barrus | |||
Kristen L Capogrossi | |||
P2860 | cites work | Two cases of "cannabis acute psychosis" following the administration of oral cannabis | Q21260289 |
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy | Q24187798 | ||
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects | Q24606148 | ||
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC | Q24634909 | ||
Human cannabinoid pharmacokinetics | Q24652736 | ||
Adverse health effects of marijuana use | Q26861513 | ||
The toxicology of cannabis and cannabis prohibition | Q28241637 | ||
Literacy and misunderstanding prescription drug labels | Q28276402 | ||
Patient Understanding of Food Labels | Q29299881 | ||
Cannabinoids for Medical Use | Q29391539 | ||
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis | Q30047193 | ||
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain | Q33578856 | ||
Cancer cachexia and cannabinoids | Q33781037 | ||
Smoked marijuana as a cause of lung injury | Q33989654 | ||
Pharmacokinetics and pharmacodynamics of cannabinoids | Q34185013 | ||
Cannabinoid hyperemesis syndrome | Q34239091 | ||
Do Plasma Concentrations of Δ9-Tetrahydrocannabinol Reflect the Degree of Intoxication? | Q51255437 | ||
Barriers and facilitators to cannabis treatment. | Q51801858 | ||
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana | Q52264943 | ||
Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion. | Q52267219 | ||
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product--Colorado, March 2014. | Q53946966 | ||
Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado | Q57841797 | ||
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use | Q59488270 | ||
How well do consumers understand percentage daily value on food labels? | Q73729229 | ||
Edible Cannabis-Induced Psychosis: Intoxication and Beyond | Q86042345 | ||
Half-baked--the retail promotion of marijuana edibles | Q86904589 | ||
Characterization of edible marijuana product exposures reported to United States poison centers | Q39600424 | ||
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? | Q39907915 | ||
Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol | Q39948828 | ||
Trends in registered medical marijuana participation across 13 US states and District of Columbia. | Q40190400 | ||
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy. | Q40313345 | ||
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. | Q41487523 | ||
Inadvertent ingestion of marijuana - Los Angeles, California, 2009. | Q43281031 | ||
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans | Q44233097 | ||
Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers | Q44332720 | ||
Characterization of the absorption phase of marijuana smoking | Q44377491 | ||
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products | Q44669607 | ||
Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood | Q46391618 | ||
Abuse potential of dronabinol (Marinol). | Q46392742 | ||
THC can be detected in brain while absent in blood | Q46852374 | ||
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles | Q46886354 | ||
Self-Medication of Somatic and Psychiatric Conditions Using Botanical Marijuana. | Q47916065 | ||
Cannabis with high cannabidiol content is associated with fewer psychotic experiences | Q48868841 | ||
Blurred boundaries: the therapeutics and politics of medical marijuana | Q34251969 | ||
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010). | Q34315874 | ||
The pharmacologic and clinical effects of medical cannabis. | Q34326515 | ||
Marijuana use and risk of lung cancer: a 40-year cohort study | Q34356964 | ||
Epidemiologic review of marijuana use and cancer risk | Q34438543 | ||
Adverse effects of cannabis | Q34482452 | ||
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. | Q34486089 | ||
Cannabinoids in the Treatment of Epilepsy | Q34493353 | ||
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep | Q34641364 | ||
Impact of Cannabis Use on the Development of Psychotic Disorders | Q34668606 | ||
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? | Q34676610 | ||
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions | Q34722366 | ||
Stigma among California's Medical Marijuana Patients | Q35124951 | ||
The implications of marijuana legalization in Colorado | Q35500385 | ||
Psychiatric and medical management of marijuana intoxication in the emergency department | Q35592725 | ||
Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence | Q35651468 | ||
Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007-2013. | Q35748033 | ||
Consumer understanding and use of nutrition labelling: a systematic review | Q36037621 | ||
Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants | Q36329247 | ||
Towards the use of non-psychoactive cannabinoids for prostate cancer | Q36603185 | ||
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study | Q36647069 | ||
Teen Use of Marijuana Edibles: A Focus Group Study of an Emerging Issue | Q36892724 | ||
Marijuana Tourism and Emergency Department Visits in Colorado | Q36930033 | ||
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. | Q36936213 | ||
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis | Q37006281 | ||
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers | Q37103395 | ||
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. | Q37285983 | ||
Chronic toxicology of cannabis | Q37544803 | ||
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours | Q37562364 | ||
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine | Q37871980 | ||
Association of unintentional pediatric exposures with decriminalization of marijuana in the United States | Q38186173 | ||
Toking, Vaping, and Eating for Health or Fun: Marijuana Use Patterns in Adults, U.S., 2014. | Q38546980 | ||
A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. | Q39173338 | ||
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. | Q39219604 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P577 | publication date | 2016-11-01 | |
P1476 | title | Tasty THC: Promises and Challenges of Cannabis Edibles | |
P478 | volume | 2016 |
Q52646288 | Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods. |
Q64232401 | Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review |
Q90626055 | Cannabis and mental illness: a review |
Q88907845 | Cannabis regulatory science: risk-benefit considerations for mental disorders |
Q57300431 | Comparison of the locations where young adults smoke, vape, and eat/drink cannabis: Implications for harm reduction |
Q89652292 | Complex cannabis use patterns: Associations with cannabis consequences and cannabis use disorder symptomatology |
Q54525669 | Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats. |
Q92452522 | Health considerations of the legalization of cannabis edibles |
Q90115713 | Insights into the role of cannabis in the management of inflammatory bowel disease |
Q92709700 | Joint and separate exposure to alcohol and ∆9-tetrahydrocannabinol produced distinct effects on glucose and insulin homeostasis in male rats |
Q47658270 | Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship? |
Q92169824 | Marijuana Use in Pregnancy: A Review |
Q99413706 | Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats |
Q50041116 | Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. |
Q64130865 | Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017 |
Q92972277 | Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood |